26dkou145 10.3205/26dkou145 urn:nbn:de:0183-26dkou1459 Meeting Abstract Tibesku Tibesku Carsten C

KniePraxis Prof. Dr. Tibesku, Straubing, Deutschland

author Ait Si Selmi Ait Si Selmi Tarik T

Centre Orthopédique Santy, Lyon, Frankreich

author Müller Müller Jacobus J

ReSurg, Nyon, Schweiz

author Saffarini Saffarini Mo M

ReSurg, Nyon, Schweiz

author Bonnin Bonnin Michel M

Centre Orthopédique Santy, Lyon, Frankreich

author German Medical Science GMS Publishing House

Düsseldorf

610 20261020 engl This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License. Dieser Artikel ist ein Open-Access-Artikel und steht unter den Lizenzbedingungen der Creative Commons Attribution 4.0 License (Namensnennung). M0659 145 Deutsche Gesellschaft für Orthopädie und Unfallchirurgie Deutsche Gesellschaft für Orthopädie und Orthopädische Chirurgie Deutsche Gesellschaft für Unfallchirurgie Berufsverband für Orthopädie und Unfallchirurgie Deutscher Kongress für Orthopädie und Unfallchirurgie (DKOU 2026) Abstracts | Robotik und technologische Innovationen in der Knieendoprothetik Berlin 20261020 20261023 DKOU26_Abs_2093 TextObjectives and questions: The purpose of this multicentre observational study is to evaluate implant survival and patient-reported outcome measures (PROMs) at 3–5 years following individualised total knee arthroplasty (TKA).Material and methods: A consecutive series of 426 patients (434 knees) underwent CT-based, posterior-stabilised, cemented, individualised TKA between December 2018 and August 2020. After excluding 73 patients without informed consent, 353 patients (361 knees) were included for survival analysis. A further 74 were excluded (revised = 2, deceased = 11, inadequate follow-up = 61), resulting in a final cohort of 279 patients (287 knees) for PROMs assessment. Implant survival was evaluated using the Kaplan–Meier (KM) method, with revision of any component for any reason as the endpoint at 2- and 3-year follow-ups. Patients completed pre and postoperative questionnaires of the Oxford knee score (OKS) and the forgotten joint score (FJS), and also rated their level of satisfaction on a 4-level Likert scale. The proportion of patients who achieved a patient acceptable symptom state (PASS) was estimated according to the threshold of 30 for OKS and 38 for FJS.Results: Considering revision for any reason as endpoint, the survival according to the KM method was 99.4% (95%C.I. 98.6%–100.0%) at both 2- and 3-year follow-up. The OKS improved from 22.2 ± 8.4 to 40.6 ± 7.6, and 244 knees (85%) achieved the PASS. The FJS improved from 16.7 ± 14.6 to 68.5 ± 27.7, and 233 (81%) achieved the PASS. Out of the 254 knees with their rated level of satisfaction, 250 (98.4%) were either satisfied or very satisfied.Discussion and conclusions: At 3 to 5 years’ follow-up, individualised TKA demonstrated excellent implant survival (99.4%), as well as high patient satisfaction, both considering and disregarding non-respondents (87.1% and 98.4% respectively). The results are promising and warrant continued follow-up to evaluate long-term results. 0 0 0 0